0001415889-18-000791.txt : 20180521 0001415889-18-000791.hdr.sgml : 20180521 20180521161515 ACCESSION NUMBER: 0001415889-18-000791 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180518 FILED AS OF DATE: 20180521 DATE AS OF CHANGE: 20180521 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KAPLAN GILLA CENTRAL INDEX KEY: 0001247024 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34912 FILM NUMBER: 18849765 MAIL ADDRESS: STREET 1: C/O CELGENE CORPORATION STREET 2: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 FORMER NAME: FORMER CONFORMED NAME: KAPLAN GILLA PHD DATE OF NAME CHANGE: 20030625 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CELGENE CORP /DE/ CENTRAL INDEX KEY: 0000816284 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 222711928 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 BUSINESS PHONE: (908)673-9000 MAIL ADDRESS: STREET 1: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 4 1 form4-05212018_040501.xml X0306 4 2018-05-18 0000816284 CELGENE CORP /DE/ CELG 0001247024 KAPLAN GILLA 86 MORRIS AVENUE SUMMIT NJ 07901 true false false false Common Stock 2018-05-18 4 M 0 27750 30.01 A 104051 D Common Stock 2018-05-18 4 S 0 27750 78.6576 D 76301 D Stock Option (right to buy) 30.01 2018-05-18 4 M 0 27750 0 D 2018-06-18 Common Stock 27750 0 D The price reported in Column 4 is a weighted average price. These shares were sold by the reporting person in multiple transactions at prices ranging from $78.62 to $78.74, inclusive. The reporting person undertakes to provide to Celgene Corporation (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4. The option was fully exercisable. The option was issued pursuant to the Company's 1995 Non-Employee Director's Incentive Plan. /s/ Peter N. Kellogg, Attorney-in-Fact 2018-05-21